Integra LifeSciences Holdings Corporation (IART) Social Stream
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IART.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $88 | $72 | $80.166 | $39.63 | 102.29% |
| 2021-11-10 | 8 | $88 | $55.001 | $76.571 | $39.63 | 93.21% |
| 2022-01-06 | 8 | $88 | $55 | $76.571 | $39.63 | 93.21% |
| 2022-01-18 | 7 | $88 | $65 | $77.666 | $39.63 | 95.98% |
| 2022-02-24 | 8 | $80 | $65 | $72.166 | $39.63 | 82.1% |
| 2022-04-27 | 8 | $80 | $65 | $72 | $39.63 | 81.68% |
| 2022-04-28 | 7 | $78 | $65 | $69 | $39.63 | 74.11% |
| 2022-05-17 | 7 | $78 | $65 | $68.666 | $39.63 | 73.27% |
| 2022-07-25 | 8 | $78 | $55 | $63.857 | $39.63 | 61.13% |
| 2022-07-28 | 8 | $70 | $55 | $61 | $39.63 | 53.92% |
| 2022-07-29 | 8 | $70 | $55 | $62.428 | $39.63 | 57.53% |
| 2022-08-24 | 8 | $70 | $55 | $61.285 | $39.63 | 54.64% |
| 2022-09-14 | 8 | $70 | $50 | $60.428 | $39.63 | 52.48% |
| 2022-09-17 | 7 | $70 | $50 | $60.428 | $39.63 | 52.48% |
| 2022-10-05 | 7 | $70 | $50 | $58 | $39.63 | 46.35% |
| 2022-10-11 | 8 | $70 | $49 | $56.714 | $39.63 | 43.11% |
| 2022-10-12 | 8 | $70 | $48 | $55.625 | $39.63 | 40.36% |
| 2022-10-17 | 8 | $70 | $46 | $53.875 | $39.63 | 35.94% |
| 2022-10-21 | 8 | $66 | $46 | $51.75 | $39.63 | 30.58% |
| 2022-12-02 | 9 | $75 | $48 | $54.777 | $39.63 | 38.22% |
| 2022-12-12 | 10 | $75 | $48 | $55.888 | $39.63 | 41.02% |
| 2022-12-15 | 10 | $75 | $50 | $56.777 | $39.63 | 43.27% |
| 2022-12-20 | 10 | $75 | $50 | $57.444 | $39.63 | 44.95% |
| 2023-01-06 | 10 | $75 | $50 | $58.444 | $39.63 | 47.47% |
| 2023-02-17 | 10 | $75 | $50 | $59.111 | $39.63 | 49.16% |
| 2023-03-03 | 10 | $75 | $50 | $59.777 | $39.63 | 50.84% |
| 2023-04-26 | 10 | $75 | $50 | $60.222 | $39.63 | 51.96% |
| 2023-05-15 | 10 | $66 | $50 | $58.444 | $39.63 | 47.47% |
| 2023-05-18 | 10 | $66 | $50 | $58 | $39.63 | 46.35% |
| 2023-05-23 | 10 | $66 | $39 | $55.777 | $39.63 | 40.74% |
| 2023-05-24 | 10 | $66 | $39 | $54.333 | $39.63 | 37.1% |
| 2023-06-06 | 11 | $65 | $39 | $49.222 | $39.63 | 24.2% |
| 2023-06-23 | 11 | $65 | $39 | $48 | $39.63 | 21.12% |
| 2023-07-12 | 11 | $65 | $39 | $47.444 | $39.63 | 19.72% |
| 2023-07-19 | 11 | $65 | $39 | $47.888 | $39.63 | 20.84% |
| 2023-07-28 | 11 | $65 | $39 | $48 | $39.63 | 21.12% |
| 2023-08-13 | 11 | $60 | $39 | $47.222 | $39.63 | 19.16% |
| 2023-08-24 | 11 | $60 | $39 | $47.222 | $39.63 | 19.16% |
The Trend in the Analyst Price Target
IART's average price target has moved down $24.94 over the prior 18 months.
Over the past 46 weeks, IART's average upside potential has been 13.88%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-21 | 8 | 66 | 46 | 51.750 | 42.87 | 20.71% |
| 2022-12-02 | 9 | 75 | 48 | 54.777 | 56.46 | -2.98% |
| 2023-06-06 | 11 | 65 | 39 | 49.222 | 40.67 | 21.03% |
| 2023-08-13 | 11 | 60 | 39 | 47.222 | 43.66 | 8.16% |
| 2023-08-24 | 11 | 60 | 39 | 47.222 | 41.03 | 15.09% |
IART Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.03 | 3 | 0 | 4 | 3 | 3 | 11 |
The Trend in the Broker Recommendations
IART's average broker recommendation rating worsened by 0.57 over the prior 42 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IART as an investment opportunity.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, INTEGRA LIFESCIENCES HOLDINGS CORP's average analyst price target is higher than 3148.1% of them.
- INTEGRA LIFESCIENCES HOLDINGS CORP's variance in analysts' estimates is lower than -1295.9% of Healthcare stocks.
- In the context of stocks in the mid market cap category, INTEGRA LIFESCIENCES HOLDINGS CORP's number of analysts covering the stock is higher than 2853.09% of them.
- In the context of Healthcare stocks, INTEGRA LIFESCIENCES HOLDINGS CORP's upside potential (average analyst target price relative to current price) is greater than 1610% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to INTEGRA LIFESCIENCES HOLDINGS CORP are ICUI, MMSI, and HAE.
View All Top Stocks by Price Target
What is the outlook for IART? Use POWR Ratings for clearer insight into price direction.